These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25652468)
1. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. Amornpisutt R; Proungvitaya S; Jearanaikoon P; Limpaiboon T Tumour Biol; 2015 Jul; 36(7):4973-8. PubMed ID: 25652468 [TBL] [Abstract][Full Text] [Related]
2. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases. Wasenang W; Chaiyarit P; Proungvitaya S; Limpaiboon T Clin Epigenetics; 2019 Mar; 11(1):39. PubMed ID: 30832707 [TBL] [Abstract][Full Text] [Related]
3. Validation of methylation-sensitive high resolution melting for the detection of DNA methylation in cholangiocarcinoma. Amornpisutt R; Sriraksa R; Limpaiboon T Clin Biochem; 2012 Sep; 45(13-14):1092-4. PubMed ID: 22569599 [TBL] [Abstract][Full Text] [Related]
4. CpG-island methylation study of liver fluke-related cholangiocarcinoma. Sriraksa R; Zeller C; El-Bahrawy MA; Dai W; Daduang J; Jearanaikoon P; Chau-In S; Brown R; Limpaiboon T Br J Cancer; 2011 Apr; 104(8):1313-8. PubMed ID: 21448164 [TBL] [Abstract][Full Text] [Related]
6. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013 [TBL] [Abstract][Full Text] [Related]
7. Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Andresen K; Boberg KM; Vedeld HM; Honne H; Jebsen P; Hektoen M; Wadsworth CA; Clausen OP; Lundin KE; Paulsen V; Foss A; Mathisen Ø; Aabakken L; Schrumpf E; Lothe RA; Lind GE Hepatology; 2015 May; 61(5):1651-9. PubMed ID: 25644509 [TBL] [Abstract][Full Text] [Related]
8. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival. Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526 [TBL] [Abstract][Full Text] [Related]
9. Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma. Khamko R; Wasenang W; Daduang J; Settasatian C; Limpaiboon T In Vivo; 2022; 36(3):1168-1177. PubMed ID: 35478117 [TBL] [Abstract][Full Text] [Related]
11. Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells. Cheng W; Qi Y; Tian L; Wang B; Huang W; Chen Y Cell Death Dis; 2017 Feb; 8(2):e2628. PubMed ID: 28230864 [TBL] [Abstract][Full Text] [Related]
12. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma. Andresen K; Boberg KM; Vedeld HM; Honne H; Hektoen M; Wadsworth CA; Clausen OP; Karlsen TH; Foss A; Mathisen O; Schrumpf E; Lothe RA; Lind GE Epigenetics; 2012 Nov; 7(11):1249-57. PubMed ID: 22983262 [TBL] [Abstract][Full Text] [Related]
13. Detection of circulating methylated opioid binding protein/cell adhesion molecule-like gene as a biomarker for ovarian carcinoma. Zhou F; Ma M; Tao G; Chen X; Xie W; Wang Y; Cao X Clin Lab; 2014; 60(5):759-65. PubMed ID: 24839818 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer. Hu H; Wang T; Pan R; Yang Y; Li B; Zhou C; Zhao J; Huang Y; Duan S Pathol Oncol Res; 2019 Apr; 25(2):567-575. PubMed ID: 30368728 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma. Nanok C; Jearanaikoon P; Proungvitaya S; Limpaiboon T Mol Med Rep; 2018 Mar; 17(3):4145-4153. PubMed ID: 29359783 [TBL] [Abstract][Full Text] [Related]
16. Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer. Lian B; Li H; Liu Y; Chai D; Gao Y; Zhang Y; Zhou J; Li J Breast Cancer; 2021 Mar; 28(2):448-458. PubMed ID: 33108608 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma. Liang Z; Liu X; Zhang Q; Wang C; Zhao Y Dig Liver Dis; 2016 Oct; 48(10):1227-32. PubMed ID: 27476468 [TBL] [Abstract][Full Text] [Related]
18. Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer. Wu Y; Davison J; Qu X; Morrissey C; Storer B; Brown L; Vessella R; Nelson P; Fang M Epigenetics; 2016 Apr; 11(4):247-58. PubMed ID: 26890304 [TBL] [Abstract][Full Text] [Related]
19. Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer. Xing BL; Li T; Tang ZH; Jiao L; Ge SM; Qiang X; OuYang J Genet Mol Res; 2015 May; 14(2):4532-40. PubMed ID: 25966226 [TBL] [Abstract][Full Text] [Related]